American Journal of Cardiology
Volume 104, Issue 1 , Pages 5-8 , 1 July 2009

Rate of Acute ST-Elevation Myocardial Infarction in the United States from 1988 to 2004 (from the Nationwide Inpatient Sample)

  • Mohammad Reza Movahed, MD, PhD

      Affiliations

    • Division of Cardiology, Southern Arizona VA Health Care System, Tucson, Arizona
    • Division of Cardiology, University of Arizona Sarver Heart Center, Tucson, Arizona
    • Corresponding Author InformationCorresponding author: Tel: 520-626-5431; fax: 520-626-5181
    • ,
  • Radhakrishnan Ramaraj, MD, MHSA

      Affiliations

    • Division of Cardiology, University of Arizona Sarver Heart Center, Tucson, Arizona
    • ,
  • Mehrnoosh Hashemzadeh, PhD

      Affiliations

    • Division of Cardiology, University of Arizona Sarver Heart Center, Tucson, Arizona
    • ,
  • M. Mazen Jamal, MD, MPH

      Affiliations

    • Department of Medicine, The VA Long Beach Healthcare System, Long Beach, California
    • ,
  • Mehrtash Hashemzadeh, MS

      Affiliations

    • Department of Medicine, The VA Long Beach Healthcare System, Long Beach, California

Received 21 December 2008 ,Revised 17 February 2009 ,Accepted 17 February 2009.

References 

  1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(suppl):e69–e171
  2. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation. 2004;110:588–636
  3. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML. Acute myocardial infarction. Lancet. 2003;361:847–858
  4. Kesteloot H, Sans S, Kromhout D. Evolution of all-causes and cardiovascular mortality in the age-group 75–84 years in Europe during the period 1970–1996; a comparison with worldwide changes. Eur Heart J. 2002;23:384–398
  5. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389
  6. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (West of Scotland Coronary Prevention Study Group). N Engl J Med. 1995;333:1301–1307
  7. Hedblad B, Wikstrand J, Janzon L, Wedel H, Berglund G. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic plaque Study (BCAPS). Circulation. 2001;103:1721–1726
  8. Mehta NJ, Khan IA. Cardiology's 10 greatest discoveries of the 20th century. Tex Heart Inst J. 2002;29:164–171
  9. Julian DG. The evolution of the coronary care unit. Cardiovasc Res. 2001;51:621–624
  10. Braunwald E. Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360–1369
  11. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(suppl):e25–e146

PII: S0002-9149(09)00662-6

doi: 10.1016/j.amjcard.2009.02.058

American Journal of Cardiology
Volume 104, Issue 1 , Pages 5-8 , 1 July 2009

Article Tools

* Image Usage & Resolution